Cyclopamine is a diterpene pyridine alkaloid and a potent Hedgehog pathway inhibitor investigated for the treatment of cancers driven by excessive Sonic hedgehog activity, including basal cell carcinoma,… Read more
Cyclopamine is a diterpene pyridine alkaloid and a potent Hedgehog pathway inhibitor investigated for the treatment of cancers driven by excessive Sonic hedgehog activity, including basal cell carcinoma, medulloblastoma, rhabdomyosarcoma, and glioblastoma. This category encompasses essential reference standards for cyclopamine, supporting rigorous pharmaceutical research and development. Laboratories utilize these high-quality materials, including the active pharmaceutical ingredient, identified impurities like cycloposine, and stable isotope-labelled compounds, to facilitate precise analytical testing and method validation. By providing access to accurate standards for impurity profiling and quantitative analysis, these compounds enable researchers to ensure the integrity of drug substance characterization and quality control processes. Scientists rely on these well-characterized materials to maintain compliance with regulatory standards and to advance studies into the therapeutic potential of Hedgehog signaling inhibition.